T5	DiversityMetric 4444 4455	α-diversity
T29	Methodology 4703 4737	principal component analysis (PCA)
T30	Methodology 4742 4795	non-metric multidimensional scaling (NMDS) statistics
T32	Physiology 8512 8535	carbohydrate metabolism
T33	Physiology 8512 8524;8540 8549	carbohydrate transport
T34	Physiology 8566 8592	xenobiotics biodegradation
T35	Physiology 8566 8577;8597 8607	xenobiotics metabolism
T49	Population 123 142	healthy individuals
T50	Population 402 411	IBD group
T51	Disease 402 405	IBD
T52	Population 705 717	IBD patients
T53	Disease 705 708	IBD
T54	Microorganism 727 737	Firmicutes
T55	Microorganism 805 819	Proteobacteria
T56	Microorganism 878 891	Bacteroidetes
T57	Microorganism 909 925	Escherichia coli
T58	Microorganism 946 960	Actinobacteria
T59	Microorganism 1012 1024	Fusobacteria
T60	Microorganism 1077 1088	Tenericutes
T61	Microorganism 1107 1128	Klebsiella pneumoniae
T62	Microorganism 1149 1164	Verrucomicrobia
T63	Microorganism 1183 1201	Bacteroides ovatus
T64	Microorganism 1227 1245	Epsilonbacteraeota
T65	Microorganism 1264 1300	Bifidobacterium longum subsp. longum
T66	Microorganism 1321 1347	PatescibacteriaChloroflexi
T67	Microorganism 1423 1448	Uncultured Bacteroides sp
T68	Methodology 1606 1614	16S rDNA
T69	Methodology 1821 1827	UCLUST
T70	Methodology 1831 1836	QIIME
T71	Population 2070 2082	IBD patients
T72	Disease 2070 2073	IBD
T73	DECREASES 2087 2094	reduced
T74	Microorganism 2105 2115	Firmicutes
T75	Microorganism 2117 2128	Bacteroides
T76	Microorganism 2130 2142	Fusobacteria
T77	Microorganism 2148 2159	Tenericutes
T78	INCREASES 2164 2173	increased
T79	Microorganism 2187 2201	Proteobacteria
T80	Microorganism 2206 2220	Actinobacteria
T81	Disease 2303 2306	IBD
T82	Population 2303 2313	IBD groups
T83	Microorganism 2529 2545	Escherichia coli
T84	Microorganism 2547 2568	Klebsiella pneumoniae
T85	Microorganism 2570 2606	Bifidobacterium longum subsp. Longum
T87	Microorganism 2608 2631	Bacteroides ovatus V975
T88	Microorganism 2665 2690	uncultured Bacteroides sp
T89	Disease 2932 2935	IBD
T90	Methodology 2905 2928	phylum-level clustering
T91	INCREASES 2962 2971	increased
T92	Microorganism 2985 2999	Proteobacteria
T93	Microorganism 3001 3015	Actinobacteria
T94	Microorganism 3021 3036	Verrucomicrobia
T95	Disease 3234 3237	IBD
T96	DECREASES 3250 3257	reduced
T97	Microorganism 3258 3269	Bacteroides
T98	Microorganism 3271 3280	Dialister
T99	Microorganism 3282 3297	Subdoligradulum
T100	Microorganism 3303 3317	Ruminococcus 2
T101	INCREASES 3323 3332	increased
T102	Microorganism 3346 3366	Escherichia-Shigella
T103	Microorganism 3371 3386	Bifidobacterium
T104	DiversityMetric 3388 3394;3404 3413	Alpha- diversity
T105	DiversityMetric 3399 3413	beta-diversity
T106	Disease 3451 3454	IBD
T107	Population 3451 3463	IBD patients
T108	DiversityMetric 3470 3481	β diversity
T109	DiversityMetric 3464 3465;3472 3481	α diversity
T110	DiversityMetric 3529 3540	α diversity
T111	DiversityMetric 3623 3634	α diversity
T112	DiversityMetric 3905 3916	β diversity
T113	DiversityMetric 4016 4027	α-diversity
T114	Disease 4256 4259	IBD
T115	Disease 4853 4856	IBD
T116	DiversityMetric 4885 4896	α-diversity
T117	DiversityMetric 5357 5368	β-diversity
T118	DiversityMetric 5476 5487	β diversity
T119	DiversityMetric 5594 5605	β-diversity
T120	Population 5613 5622	IBD group
T121	Disease 5613 5616	IBD
T122	Disease 5699 5702	IBD
T123	Disease 5760 5763	IBD
T124	Disease 5831 5834	IBD
T125	Population 5831 5840	IBD group
T126	Population 5883 5892	IBD group
T127	Disease 5883 5886	IBD
T128	Disease 5949 5952	IBD
T129	Population 5949 5958	IBD group
T130	Disease 6189 6192	IBD
T131	Biospecimen 6193 6198	stool
T132	Methodology 5801 5815	LEFSe analysis
T133	Methodology 6238 6243	LEfSe
T134	Disease 6478 6481	IBD
T135	Microorganism 6550 6565	Enterococcaceae
T136	Microorganism 6570 6586	Lactobacillaceae
T137	Microorganism 6602 6614	Enterococcus
T138	Microorganism 6616 6629	Lactobacillus
T139	Microorganism 6635 6646	Eggerthella
T140	Disease 6717 6720	IBD
T141	Population 6717 6726	IBD group
T142	ASSOCIATED_WITH 6687 6709	play an important role
T143	Methodology 6792 6819	STAMP differential analysis
T144	Disease 6895 6898	IBD
T145	Population 6895 6904	IBD group
T146	Population 6914 6927	healthy group
T147	Microorganism 6988 6997	Dialister
T148	Microorganism 6999 7008	Alistipes
T149	Microorganism 7010 7025	Subdoligranulum
T150	Microorganism 7027 7050	Ruminococcaceae UCG-002
T151	Microorganism 7027 7042;7052 7059	Ruminococcaceae UCG-005
T152	Microorganism 7027 7042;7061 7068	Ruminococcaceae UCG-010
T153	Microorganism 7074 7087	Coprococcus 2
T154	DECREASES 6958 6965	reduced
T155	INCREASES 7093 7102	increased
T156	Microorganism 7116 7128	Anaerostipes
T157	Microorganism 7131 7142	Eubacterium
T158	Microorganism 7144 7156	hallii group
T159	Microorganism 7162 7173	Eggerthella
T160	Methodology 7247 7266	KEGG STAMP analysis
T161	Methodology 7336 7356	COG heatmap analysis
T162	Methodology 7426 7444	COG STAMP analysis
T163	Disease 7855 7858	IBD
T164	Methodology 7891 7898	PICRUSt
T165	Methodology 8032 8046	16S sequencing
T166	Methodology 8165 8195	COG homologous protein cluster
T167	Methodology 8271 8275	KEGG
T168	Methodology 8353 8357	KEGG
T169	Methodology 8362 8365	COG
T170	Disease 8436 8439	IBD
T171	Population 8436 8445	IBD group
T172	Methodology 8450 8464	STAMP analysis
T173	Disease 8933 8936	IBD
T174	Population 8933 8942	IBD group
T175	Methodology 8954 8972	LEfSe LDA analysis
T176	Methodology 8982 9012	COG homologous protein cluster
T177	Disease 9154 9157	IBD
T178	Population 9154 9163	IBD group
T179	DECREASES 9175 9182	reduced
T180	Physiology 9183 9218	translation of ribosomal structures
T181	Physiology 9198 9207;9223 9233	ribosomal biogenesis
T182	Physiology 9239 9258	chromatin structure
T183	Physiology 9239 9248;9263 9271	chromatin dynamics
T184	INCREASES 9064 9072	elevated
T185	Physiology 9073 9095	carbohydrate transport
T186	Physiology 9073 9085;9100 9110	carbohydrate metabolism
T187	Physiology 9115 9146	RNA processing and modification
T188	Disease 9467 9470	IBD
T189	Disease 9797 9800	IBD
T190	Physiology 9825 9857	Vitamin digestion and absorption
T191	Physiology 9859 9889	primary bile acid biosynthesis
T192	Physiology 9891 9923	protein digestion and absorption
T193	Gene 9925 9941	ABC transporters
T194	Disease 9943 9963	basal cell carcinoma
T195	Physiology 9965 9987	glutathione metabolism
T196	Disease 9989 10000	ferroptosis
T197	Disease 21898 21901	IBD
T198	Disease 21998 22001	IBD
T199	Microorganism 21744 21755	Eggerthella
T200	Methodology 21184 21199	Cytoscape 3.5.1
T201	Microorganism 21785 21797	Enterococcus
T202	Microorganism 20776 20789	Lactobacillus
T203	POS_ASSOCIATED_WITH 20794 20826	positive significant correlation
T204	Metabolite 20856 20864	L-valine
T205	Metabolite 20878 20898	N-nitrosopyrrolidine
T206	Metabolite 20900 20909	calycosin
T207	Metabolite 20911 20919	apigenin
T208	Metabolite 20921 20942	flavin mononucleotide
T209	Metabolite 20944 20951	his-met
T210	Metabolite 20953 20961	luteolin
T211	Metabolite 20967 20985	1,2,3-benzenetriol
T212	NEG_ASSOCIATED_WITH 21002 21034	negative significant correlation
T213	Metabolite 21065 21086	25-hydroxycholesterol
T214	Metabolite 21088 21100	androsterone
T216	Metabolite 21102 21117	ginsenoside rh2
T217	Metabolite 21119 21130	pristimerin
T218	Metabolite 21136 21147	cholesterol
T219	Microorganism 20441 20452	Eggerthella
T220	Microorganism 19865 19877	Enterococcus
T221	Metabolite 20743 20762	piperonyl sulfoxide
T222	Metabolite 20729 20741	Asiatic acid
T223	Metabolite 20719 20727	neomycin
T224	Metabolite 20705 20717	hypoxanthine
T225	Metabolite 20687 20703	lithocholic acid
T226	Metabolite 20673 20685	salvinorin a
T227	Metabolite 20662 20671	hecogenin
T228	NEG_ASSOCIATED_WITH 20610 20631	negatively correlated
T229	Metabolite 20585 20593	luteolin
T230	Metabolite 20572 20579	his-met
T231	Metabolite 20549 20570	flavin mononucleotide
T232	Metabolite 20539 20547	apigenin
T233	Metabolite 20528 20537	calycosin
T234	Metabolite 20517 20526	delsoline
T235	Metabolite 20505 20515	corydaline
T236	POS_ASSOCIATED_WITH 20453 20474	positively correlated
T237	POS_ASSOCIATED_WITH 19882 19914	positive significant correlation
T238	Metabolite 19945 19956	cholic acid
T239	Metabolite 19958 19967	calycosin
T240	Metabolite 19973 19993	N-nitrosopyrrolidine
T241	Metabolite 20011 20032	flavin mononucleotide
T242	Metabolite 20034 20042	apigenin
T243	Metabolite 20044 20052	L-valine
T246	Metabolite 20058 20114	3alpha,7beta,12alpha-trihydroxy-5beta-cholan-24-oic acid
T247	NEG_ASSOCIATED_WITH 20131 20165	negatively significant correlation
T248	Metabolite 20196 20211	ginsenoside rh2
T249	Metabolite 20213 20225	androsterone
T250	Metabolite 20227 20250	indole-3-carboxaldehyde
T251	Metabolite 20252 20264	salvinorin a
T252	Metabolite 20266 20285	isodeoxycholic acid
T253	Metabolite 20291 20307	lithocholic acid
T254	Metabolite 20325 20333	glycerol
T255	Metabolite 20335 20341	uracil
T256	Metabolite 20343 20353	oxypurinol
T257	Metabolite 20355 20376	25-hydroxycholesterol
T258	Metabolite 20378 20398	glycolithocholic aid
T259	Metabolite 20400 20408	xanthine
T260	Metabolite 20414 20428	hypoxyxanthine
T261	Methodology 19295 19312	Spearman analysis
T262	Methodology 18898 18927	Spearman correlation analysis
T263	Population 19086 19095	IBD group
T264	Disease 19086 19089	IBD
T265	Microorganism 19181 19192	Eggerthella
T266	Microorganism 19194 19206	Enterococcus
T267	Microorganism 19208 19221	Lactobacillus
T268	Methodology 19336 19375	correlation coefficient matrix heat map
T269	Methodology 19380 19412	hierarchical clustering heat map
T270	Methodology 17872 17920	Spearman correlation coefficient matrix heat map
T271	Methodology 17972 18034	Spearman correlation analysis hierarchical clustering heat map
T272	Disease 17772 17775	IBD
T273	Disease 17673 17676	IBD
T274	Population 17673 17685	IBD patients
T275	Population 17698 17717	healthy individuals
T276	Methodology 17258 17284	Pathway hierarchy analysis
T277	Disease 17316 17319	IBD
T278	Population 17316 17328	IBD patients
T279	Physiology 17338 17353	cancer function
T280	Physiology 17355 17376	cell growth and death
T281	Physiology 17396 17412	lipid metabolism
T282	Physiology 17414 17432	membrane transport
T283	Physiology 17438 17461	metabolism of cofactors
T284	Physiology 17438 17451;17463 17471	metabolism of vitamins
T285	Physiology 17438 17451;17483 17494	metabolism of amino acids
T286	Methodology 17153 17157	KEGG
T287	Gene 17086 17099	ABC transport
T288	Physiology 16793 16825	vitamin digestion and absorption
T289	Physiology 16827 16857	primary bile acid biosynthesis
T290	Physiology 16859 16876	protein digestion
T291	Physiology 16859 16866;16882 16892	protein absorption
T292	Physiology 16894 16913	thiamine metabolism
T293	Physiology 16915 16937	glutathione metabolism
T294	Gene 16939 16955	ABC transporters
T295	Physiology 16957 16992	central carbon metabolism in cancer
T296	Disease 16986 16992	cancer
T297	Disease 16998 17009	ferroptosis
T298	Methodology 16518 16550	KEGG pathway enrichment analysis
T299	Methodology 16579 16598	Fisher’s Exact Test
T300	Disease 16685 16688	IBD
T301	Physiology 16653 16681	signal transduction pathways
T302	Physiology 16639 16648;16660 16681	metabolic transduction pathways
T303	Population 15111 15120	IBD group
T304	Disease 15111 15114	IBD
T305	Methodology 14757 14813	KEGG pathway differential metabolite clustering heat map
T306	Gene 14817 14830	ABC transport
T307	Methodology 14834 14871	KEGG metabolic pathway enrichment map
T308	Disease 14437 14440	IBD
T309	Methodology 14377 14389	AUC analysis
T310	Disease 14037 14040	IBD
T311	Metabolite 14077 14104	6,7,4′-trihydroxyisoflavone
T312	Metabolite 14119 14154	thyroxine 4'-o-.beta.-d-glucuronide
T313	Metabolite 14169 14183	trichostachine
T314	Metabolite 14198 14209	normorphine
T315	Metabolite 14228 14240	salvinorin a
T316	Disease 10943 10946	IBD
T317	Metabolite 11634 11661	6,7,4'-trihydroxyisoflavone
T318	Physiology 8624 8648	transport of amino acids
T319	Disease 11843 11846	IBD
T320	Population 11843 11852	IBD group
T321	Methodology 11911 11999	ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry
T322	Methodology 12001 12015	UHPLC-Q-TOF MS
T323	Disease 12348 12351	IBD
T324	Metabolite 13151 13160	Calycosin
T325	Metabolite 13162 13169	His-Met
T326	Metabolite 13171 13189	1,2,3-benzenetriol
T327	Metabolite 13191 13209	G(8-o-4)fa sulfate
T328	Metabolite 13215 13240	Alpha.-apooxytetracycline
T329	Metabolite 13280 13296	Lithocholic acid
T330	Metabolite 13298 13307	Clausarin
T331	Metabolite 13309 13324	Ginsenoside rh2
T332	Metabolite 13326 13345	Isodeoxycholic acid
T333	Metabolite 13351 13370	Propylpyrazoletriol
T334	Physiology 8609 8619;8634 8648	metabolism of amino acids
T335	Metabolite 11672 11807	[(2r,3 s,4 s,5r,6r)-3,4,5-trihydroxy-6-[2-(3-hydroxy-5-oxooxolan-3-yl)propoxy]oxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
T336	Metabolite 21760 21779	piperonyl sulfoxide
T337	Metabolite 21802 21822	N-nitrosopyrrolidine
T338	Metabolite 13483 13507	P-methoxymethamphetamine
T339	Metabolite 13509 13517	Apigenin
T340	Metabolite 13519 13537	O-methylarmepavine
T341	Metabolite 13539 13575	2,5-dimethoxy-4-methylphenethylamine
T342	Metabolite 13581 13589	Luteolin
T344	Metabolite 13598 13790	1(2 h)-pyrimidineacetamide, n-[(1 s,3 s,4 s)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-.alpha.-(1-methylethyl)-2-oxo-, (.alpha.s)-
T346	Metabolite 13792 13807	Isocaproic acid
T347	Metabolite 13809 13824	Garcinolic acid
T348	Metabolite 13826 13854	Anhydroecgonine methyl ester
T349	Metabolite 13860 13872	Salvinorin a
T350	Metabolite 10094 10121	6,7,4′-trihydroxyisoflavone
T351	Metabolite 10129 10164	Thyroxine 4′-o-.beta.-d-glucuronide
T352	Metabolite 10172 10186	Trichostachine
T353	Metabolite 10194 10329	[(2r,3 s,4 s,5r,6r)-3,4,5-trihydroxy-6-[2-(3-hydroxy-5-oxooxolan-3-yl)propoxy]oxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
T354	Metabolite 10337 10348	Normorphine
T355	Metabolite 10356 10368	Salvinorin a
T356	Metabolite 10376 10385	Esculetin
T357	Metabolite 10393 10406	Mitraphylline
T358	Metabolite 10414 10437	Indole-3-carboxaldehyde
T359	Metabolite 10445 10460	Ginsenoside rh2
T360	Metabolite 10468 10489	Arachidonoylserotonin
T361	Metabolite 10497 10547	11-hydroxy-5z,8z,12e,14z,17z-eicosapentaenoic acid
T362	Metabolite 10555 10578	10-deacetylbaccatin iii
T363	Metabolite 10586 10599	9-cis-retinol
T364	Metabolite 10607 10674	(5-benzoyloxy-3-chloro-4,6-dihydroxycyclohexen-1-yl)methyl benzoate
T365	Metabolite 10682 10776	[(4e)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (e)-but-2-enoate
T366	Metabolite 10784 10800	Dihydroberberine
T367	Metabolite 10808 10829	N-nitrosopyrroolidine
T368	Metabolite 10837 10852	Prothioconazole
T369	Metabolite 10860 10877	Patchouli alcohol
T4611	Disease 45 48	IBD
T4711	Population 53 72	healthy individuals
T4811	Disease 115 118	IBD
E15	DECREASES:T73 Agent:T72 Theme:T74
E16	INCREASES:T78 Agent:T72 Theme:T79
E17	DECREASES:T73 Agent:T72 Theme:T75
E18	DECREASES:T73 Agent:T72 Theme:T76
E19	DECREASES:T73 Agent:T72 Theme:T77
E20	INCREASES:T78 Agent:T72 Theme:T80
E21	INCREASES:T91 Agent:T89 Theme:T92
E22	INCREASES:T91 Agent:T89 Theme:T93
E23	INCREASES:T91 Agent:T89 Theme:T94
E24	DECREASES:T96 Agent:T95 Theme:T97
E25	INCREASES:T101 Agent:T95 Theme:T102
E26	DECREASES:T96 Agent:T95 Theme:T98
E27	DECREASES:T96 Agent:T95 Theme:T99
E28	DECREASES:T96 Agent:T95 Theme:T100
E29	INCREASES:T101 Agent:T95 Theme:T103
E30	ASSOCIATED_WITH:T142 Theme:T139 Theme2:T140
E31	ASSOCIATED_WITH:T142 Theme:T138 Theme2:T140
E32	ASSOCIATED_WITH:T142 Theme:T137 Theme2:T140
E33	ASSOCIATED_WITH:T142 Theme:T136 Theme2:T140
E34	ASSOCIATED_WITH:T142 Theme:T135 Theme2:T140
E35	DECREASES:T154 Agent:T144 Theme:T147
E36	INCREASES:T155 Agent:T144 Theme:T156
E37	INCREASES:T155 Agent:T144 Theme:T157
E38	INCREASES:T155 Agent:T144 Theme:T159
E39	DECREASES:T154 Agent:T144 Theme:T148
E40	DECREASES:T154 Agent:T144 Theme:T149
E41	DECREASES:T154 Agent:T144 Theme:T153
E42	DECREASES:T154 Agent:T144 Theme:T152
E43	DECREASES:T154 Agent:T144 Theme:T151
E44	DECREASES:T154 Agent:T144 Theme:T150
E45	DECREASES:T179 Agent:T177 Theme:T183
E46	INCREASES:T184 Agent:T177 Theme:T186
E47	INCREASES:T184 Agent:T177 Theme:T185
E48	INCREASES:T184 Agent:T177 Theme:T187
E49	DECREASES:T179 Agent:T177 Theme:T182
E50	DECREASES:T179 Agent:T177 Theme:T181
E51	DECREASES:T179 Agent:T177 Theme:T180
E52	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T204
E53	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T218
E54	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T205
E55	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T206
E56	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T207
E57	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T208
E58	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T209
E59	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T210
E60	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T211
E61	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T217
E62	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T216
E64	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T214
E65	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T213
E66	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T227
E67	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T235
E68	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T238
E69	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T248
E70	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T239
E71	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T240
E72	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T241
E73	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T242
E74	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T243
E77	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T246
E78	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T249
E79	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T250
E80	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T251
E81	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T252
E82	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T253
E83	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T254
E84	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T255
E85	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T256
E86	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T257
E87	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T258
E88	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T259
E89	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T260
E90	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T226
E91	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T221
E92	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T222
E93	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T223
E94	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T224
E95	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T225
E96	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T234
E97	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T233
E98	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T232
E99	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T231
E100	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T230
E101	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T229
A11	Factual E15
A12	Factual E16
A13	Factual E17
A14	Factual E18
A15	Factual E19
A16	Factual E20
A17	Factual E21
A18	Factual E22
A19	Factual E23
A20	Factual E24
A21	Factual E25
A22	Factual E26
A23	Factual E27
A24	Factual E28
A25	Factual E29
A26	Factual E30
A27	Factual E31
A28	Factual E32
A29	Factual E33
A30	Factual E34
A31	Factual E35
A32	Factual E36
A33	Factual E37
A34	Factual E38
A35	Factual E39
A36	Factual E40
A37	Factual E41
A38	Factual E42
A39	Factual E43
A40	Factual E44
A41	Factual E45
A42	Factual E46
A43	Factual E47
A44	Factual E48
A45	Factual E49
A46	Factual E50
A47	Factual E51
A48	Factual E52
A49	Factual E53
A50	Factual E54
A51	Factual E55
A52	Factual E56
A53	Factual E57
A54	Factual E58
A55	Factual E59
A56	Factual E60
A57	Factual E61
A58	Factual E62
A59	Factual E64
A60	Factual E65
A61	Factual E66
A62	Factual E67
A63	Factual E68
A64	Factual E69
A65	Factual E70
A66	Factual E71
A67	Factual E72
A68	Factual E73
A69	Factual E74
A70	Factual E77
A71	Factual E78
A72	Factual E79
A73	Factual E80
A74	Factual E81
A75	Factual E82
A76	Factual E83
A77	Factual E84
A78	Factual E85
A79	Factual E86
A80	Factual E87
A81	Factual E88
A82	Factual E89
A83	Factual E90
A84	Factual E91
A85	Factual E92
A86	Factual E93
A87	Factual E94
A88	Factual E95
A89	Factual E96
A90	Factual E97
A91	Factual E98
A92	Factual E99
A93	Factual E100
A94	Factual E101